DBT: Explanation for the reviewed interim consolidated financial statements 2026
DBT: Explanation for the reviewed interim consolidated financial statements 2026
Explanation for the reviewed interim consolidated financial statements 2026 of BenTre Pharmaceutical Joint Stock Company as follows:
| Attached Files: |
| 20260829 - DBT - Explanation for the reviewed interim consolidated financial statements 2026.pdf |
HOSE